DAY ONE BIOPHARMACEUTICALS I Share Price Today: Live Updates & Key Insights
DAY ONE BIOPHARMACEUTICALS I share price today is $21.33, up 0.23%. The stock opened at $21.36 against the previous close of $21.39, with an intraday high of $21.42 and low of $21.3.
DAY ONE BIOPHARMACEUTICALS I Share Price Chart
DAY ONE BIOPHARMACEUTICALS I
DAY ONE BIOPHARMACEUTICALS I Share Price Performance
DAY ONE BIOPHARMACEUTICALS I Institutional Holdings
DAY ONE BIOPHARMACEUTICALS I Market Status
DAY ONE BIOPHARMACEUTICALS I Fundamentals
Market Cap 2214.70 M
PB Ratio 5.0155
PE Ratio 0.0
Enterprise Value 1774.32 M
Total Assets 507.83 M
Volume 6907903
DAY ONE BIOPHARMACEUTICALS I Company Financials
About DAY ONE BIOPHARMACEUTICALS I & investment objective
Company Information Day One Biopharmaceuticals, Inc., a commercial-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral and brain-penetrant type II rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It is also developing DAY301, a PTK7 targeted ADC composed of a novel humanized anti-PTK7 immunoglobulin G1 monoclonal antibody conjugated with a topoisomerase I inhibitor via a highly stable and hydrophilic modified valine-alanine (VA) cleavable linker for the treatment of patients with advanced solid tumors; and Emi-Le, an antibody-drug conjugate that targets B7- H4 conjugated to an auristatin anti-tubulin payload as a component of a proprietary linker-payload platform developed by Mersana Therapeutics that is in Phase 1 clinicla trial for the treatment of breast cancer, ovarian cancer, endometrial cancer, and adenoid cystic carcinoma (ACC). Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
Organisation Biotechnology
Employees 178
Industry Biotechnology
CEO Dr. Jeremy Bender M.B.A., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
DAY ONE BIOPHARMACEUTICALS I FAQs
What is the share price of DAY ONE BIOPHARMACEUTICALS I today?
The current share price of DAY ONE BIOPHARMACEUTICALS I is $21.33.
Can I buy DAY ONE BIOPHARMACEUTICALS I shares in India?
Yes, Indian investors can buy DAY ONE BIOPHARMACEUTICALS I shares by opening an international trading and demat account with Motilal Oswal.
How to buy DAY ONE BIOPHARMACEUTICALS I shares in India?
You can easily invest in DAY ONE BIOPHARMACEUTICALS I shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy DAY ONE BIOPHARMACEUTICALS I shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of DAY ONE BIOPHARMACEUTICALS I.
Can I buy fractional shares of DAY ONE BIOPHARMACEUTICALS I?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of DAY ONE BIOPHARMACEUTICALS I?
DAY ONE BIOPHARMACEUTICALS I has a market cap of $2214.70 M.
In which sector does DAY ONE BIOPHARMACEUTICALS I belong?
DAY ONE BIOPHARMACEUTICALS I operates in the Biotechnology sector.
What documents are required to invest in DAY ONE BIOPHARMACEUTICALS I stocks?
To invest, you typically need:
What is the PE and PB ratio of DAY ONE BIOPHARMACEUTICALS I?
The PE ratio of DAY ONE BIOPHARMACEUTICALS I is N/A and the PB ratio is 5.02.